dr. klebanoff on biosimilars reducing financial toxicity in breast cancer
Published 4 years ago • 182 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
0:43
dr. kalinsky discusses biosimilars in breast cancer
-
2:03
dr. gralow on the science of biosimilars and implementation in breast cancer
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
0:43
dr. yardley on the role of biosimilars in breast cancer
-
1:55
dr. kolberg on collecting real-world biosimilar trastuzumab data in breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
4:58
jacs talking points: early breast cancer and financial toxicity
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
4:02
financial toxicity and quality of life
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
1:11
dr. callahan on the potential benefits of biosimilars in breast cancer
-
0:52
dr. offin on potential implications of introducing biosimilars into oncology
-
1:26
biosimilars: the future of treating breast cancer
-
0:58
exploring biosimilars in the field of breast cancer
-
0:32
the potential of biosimilars in cancer treatment
-
0:38
molecular mindset: rethinking cancer
-
4:04
research news: financial distress negatively impacts well-being of breast cancer patients
-
1:24
biosimilars: from science to practice in cancer care course overview
-
4:00
why nk cells are changing cancer treatment (with dr. michael a. caligiuri)